Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China
· Delayed Price · Currency is CNY 12.11
+0.21 (1.76%)
Apr 30, 2026, 1:55 PM CST
SHA:603520 Revenue
In the year 2025, Zhejiang Starry Pharmaceutical had annual revenue of 2.45B CNY with 4.07% growth. Zhejiang Starry Pharmaceutical had revenue of 600.76M in the quarter ending December 31, 2025, with 10.09% growth.
Revenue
2.45B
Revenue Growth
+4.07%
P/S Ratio
2.13
Revenue / Employee
1.39M
Employees
1,754
Market Cap
5.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.45B | 95.55M | 4.07% |
| Dec 31, 2024 | 2.35B | 154.24M | 7.02% |
| Dec 31, 2023 | 2.20B | 64.75M | 3.04% |
| Dec 31, 2022 | 2.13B | 131.32M | 6.57% |
| Dec 31, 2021 | 2.00B | 632.83M | 46.29% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Hicin Pharmaceutical | 688.74M |
| Zhongzhu Healthcare Holding Co.,Ltd | 577.34M |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Beijing Beilu Pharmaceutical | 1.21B |
| Bide Pharmatech | 1.32B |
| Beijing Science Sun Pharmaceutical | 404.72M |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Zhejiang Sunflower Great Health | 253.87M |